Effectiveness and Safety Study of Generic Imatinib in Chronic Myeloid Leukemia Patients in Egypt

NCT03454503 · clinicaltrials.gov ↗

COMPLETED

Status

173

Enrollment

INDUSTRY

Sponsor class

Conditions

Philadelphia Chromosome-positive Chronic Myeloid Leukemia in Chronic Phase

Interventions

DRUG: Imatinib

Sponsor

Hikma Pharmaceuticals LLC